09 May 2023>: Original Paper
Outcomes of Kidney Transplantation in Older Recipients
Ehab Hammad 1ABDEF* , Dieter Broering 2A , Yaser Shah 1E , Ahmed Nazmi 1E , Amira Al Abassi 3E , Jens G. Brockmann 3E , Samir Elshouny 4BE , Layal Fajji 2B , Hassan Aleid 1E , Tariq Ali 1ACEFDOI: 10.12659/AOT.938692
Ann Transplant 2023; 28:e938692
Table 1 Demographic data of recipients.
158 | |
116 (73.4) | |
69 (65–84) | |
Living | 136 (86.1) |
Deceased | 22 (13.9) |
65–69 | 106 (67.1) |
70–75 | 42 (26.6) |
>75 | 10 (6.3) |
Diabetes | 83 (52.5) |
Unknown/other | 33 (20.9) |
Hypertension | 26 (16.5) |
Glomerulonephritis | 11 (7.0) |
Urological | 5 (3.2) |
Hypertension | 152 (96.2) |
Diabetes | 98 (62.0) |
Ischemic heart disease | 40 (25.3) |
Haemodialysis | 142 (89.9) |
Peritoneal dialysis | 8 (5.1) |
Pre-emptive | 8 (5.1) |
0 | 7 (4.4) |
1 | 26 (16.5) |
2 | 34 (21.5) |
3 | 48 (30.4) |
4–6 | 43 (27.2) |
Anti-thymocyte globulin | 95 (60.1) |
Basiliximab | 60 (38.0) |
None | 2 (1.3) |
Campath | 1 (0.6) |
Negative | 125 (79.1) |
Negative with DSAs | 16 (10.1) |
B flow positive | 11 (7.0) |
B and T positive | 6 (3.8) |
ESRD – end-stage renal disease; DSA – donor-specific antibody. |